Background
==========

Cancer is a major disease in Hong Kong with great social and economic burden. According to the Hong Kong Cancer Registry, 23,750 new cancer cases and 12,093 cancer deaths were recorded in 2006. New cancer cases in Hong Kong has been rising at a annual rate of 2% \[[@B1]\]. While surgery, radiotherapy and chemotherapy remained to be conventional cancer treatments, 80% of the cancer patients around the world consult complementary and alternative medicine (CAM) for more treatment options \[[@B2]-[@B5]\]. Chinese medicine, one of the most popular CAMs, is an available option in many cancer centres in Asia \[[@B6]-[@B8]\], North America \[[@B9],[@B10]\], and Europe \[[@B5]\].

Chinese medicine and Western medicine differ fundamentally in their etiological concepts and therapeutic approaches. In Western medicine, cancer is perceived as uncontrolled growth of malignant cells which may be treated by surgery, chemotherapy, and radiotherapy \[[@B11]\]. According to Chinese medicine theory, cancer is the manifestation of a *qi*disturbance which may be treated by mobilizing *qi*. Study results support the use of Chinese medicine to treat liver cancer and leukaemia \[[@B12],[@B13]\], and recent meta-analyses demonstrated that Chinese medicine improved tumor response to chemotherapy as well as patient\'s survival rates \[[@B14],[@B15]\]. Five common Chinese medicine modalities, namely Chinese herbal medicine, acupuncture and moxibustion, therapeutic massage, *qigong*and Chinese dietary therapy have been used to treat cancer \[[@B16]\]. Moreover, acupuncture relieves pain and acute vomiting during conventional cancer treatment \[[@B15],[@B17]\]

While some researchers suggest that Chinese medicine should be integrated into a comprehensive cancer treatment scheme \[[@B18]\], cancer patients\' attitude towards Chinese medicine is largely unknown. The present study aimed to reveal the prevalence and pattern of the use of Chinese medicine among cancer patients in Hong Kong and to assess their attitudes and intentions about such use.

Methods
=======

Participants
------------

This study was approved by the Committee on the Use of Human and Animal Subjects in Teaching and Research of the Hong Kong Baptist University (HKBU) and the Research Ethics Committee of the Hospital Authority (HA) Hong Kong. Between April 2008 and August 2008, all cancer patients attending any of the three HKBU Chinese medicine clinics and the outpatient clinics of the Department of Clinical Oncology in Queen Elizabeth Hospital (QEH) were invited to participate in this cross-sectional survey.

Oral informed consent was obtained from cancer patients before participation. Each participant completed a questionnaire, which was then checked by one of the authors (YCL). Completed and checked questionnaires were coded to mask patients\' identities. Another author (CWC) double-checked the collected questionnaire to ensure good quality.

In this paper, Chinese medicine user is defined as the person who receives treatments of Chinese herbal medicine, acupuncture and moxibustion, therapeutic massage, *qigong*, Chinese dietary therapy and/or other therapies that are based on the theory of Chinese medicine.

Questionnaire
-------------

The development of the questionnaire (in Chinese language) included four stages as follows (1) a draft questionnaire was prepared; (2) the questionnaire was reviewed by Chinese medicine experts (N = 6) and Western medicine practitioners (N = 2) were collected; (3) the draft questionnaire was revised by the authors and tested on a small group (N = 10) of cancer patients;.(4) the questionnaire was finalized. The final questionnaire consisted of three parts. The first part was about background information of the participants (e.g. age, gender, marital status, educational level), type of cancer, date of diagnosis, use of Western medicine cancer treatment and/or Chinese medicine treatment. The second part focused on participants\' perception of Western medicine treatment and/or Chinese medicine treatment, such as times to initiate Chinese medicine treatment, motivations for using Chinese medicine, whether or not their physicians were told about the use of Chinese medicine and why, responses from physicians, reasons for choosing Western medicine treatment and/or Chinese medicine treatment, satisfaction with the treatment. Finally, participants were asked whether they intended to continue or stop their use of Western medicine treatment and/or Chinese medicine treatment, or other CAM therapies in the future, and their opinion on the effectiveness of the integration of Chinese and Western medicine in their cancer treatment. In the third part, participants were asked to express their views on the integration of Chinese medicine and Western medicine in cancer treatment.

Data management and statistical analyses
----------------------------------------

YCL, one of the authors, entered the data into an Access (Microsoft, USA) database, and CWC, another author, checked the data independently. All data disagreements were resolved through further checks against raw data. Data were analyzed with the Statistical Package for Social Sciences program (SPSS 13.0, SPSS, USA). Demographic and clinical characteristic differences between Western medicine and Chinese medicine users were assessed with chi-square test. Spearman correlation between the use of Chinese medicine and other variables of interest was determined. All statistical tests were two-tailed with a confidence level of alpha of 0.05.

Results
=======

Demographic and clinical characteristics of study participants
--------------------------------------------------------------

Seven hundred and ninety-one (791) questionnaires were distributed, of which 786 (99.4%) received responses. Common cancers among the participants were lung cancer, breast cancer, colorectal cancer and nasopharyngeal cancer (Table [1](#T1){ref-type="table"}).

###### 

Demographic characteristics of the study population

  ----------------------------------------------------------------------------------------------------
  Variables                 No. of patients\   Western medicine\   Chinese medicine n(%)   *P*-value
                            n(%)               n(%)                                        
  ------------------------- ------------------ ------------------- ----------------------- -----------
  Age, years                                                                               0.061

  ≦40                       92(11.7)           45(13.4)            47(10.5)                

  41-50                     218(27.7)          78(23.1)            140(31.2)               

  51-60                     219(27.9)          94(27.9)            125(27.8)               

  ≧61                       257(32.7)          120(35.6)           135(30.5)               

  Gender                                                                                   0.285

  Male                      339(43.1)          138(40.9)           201(44.8)               

  Female                    447(56.9)          199(59.1)           248(55.2)               

  Clinical setting                                                                         \< 0.001

  Chinese medicine Clinic   117(14.9)          2(0.6)              115(25.6)               

  Western medicine Clinic   669(85.1)          335(99.4)           334(74.4)               

  Marital status                                                                           0.200

  Married                   659(83.8)          276(81.9)           383(85.3)               

  Unmarried                 127(16.2)          61(18.1)            66(14.7)                

  Education level                                                                          0.001

  Elementary school         244(31.0)          120(35.6)           124(27.6)               

  High school               374(47.6)          155(46.0)           219(48.8)               

  College or University     114(14.5)          33(9.8)             81(18.0)                

  Other                     54(6.9)            29(8.6)             25(5.6)                 
  ----------------------------------------------------------------------------------------------------

Data are presented as the actual number of patients (percentage in that group). Chi-square tests were conducted between Western medicine and Chinese medicine users.

Compared with Western medicine users, Chinese medicine users were better educated among whom Stage III or IV lung cancer, breast cancer and nasopharyngeal cancer and cancers which had been diagnosed within the last 36 months (*P*\< 0.05).

Prevalence and pattern of treatment
-----------------------------------

Nearly all participants (99.4%) used western medicine; 56.5% (N = 444) combined Western medicine with Chinese medicine, while 42.9% (N = 337) used Western medicine alone. Only 0.6% (N = 5) of the participants used Chinese medicine alone. This pattern was probably skewed towards Western medicine users because 85.1% (N = 669) participants were recruited from Western medicine clinics. Nevertheless, almost half of those patients received Chinese medicine treatment. Furthermore, the Spearman correlation coefficient study showed type of cancer (r~s~= -1.36; *P*\< 0.001), stage of cancer (r~s~= 0.178; *P*\< 0.001), time since diagnosis (r~s~= -0.074; *P*= 0.037) were correlated with the use of Chinese medicine (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}).

###### 

Clinical characteristics of study population

  ----------------------------------------------------------------------------------------------------------
  Variables                       No. of patients\   Western medicine\   Chinese medicine n(%)   *P*-value
                                  n(%)               n(%)                                        
  ------------------------------- ------------------ ------------------- ----------------------- -----------
  Cancer type                                                                                    \< 0.001

  Lung                            145(18.4)          46(13.6)            99(22.0)                

  Breast                          128(16.3)          50(14.8)            78(17.4)                

  Prostate                        22(2.8)            11(3.3)             11(2.4)                 

  Colorectal                      114(14.5)          53(15.7)            61(13.6)                

  Liver                           13(1.7)            1(0.3)              12(2.7)                 

  Stomach                         15(1.9)            4(1.2)              11(2.4)                 

  Nasopharyngeal                  117(14.9)          45(13.4)            72(16.0)                

  Cervical                        17(2.2)            12(3.6)             5(1.1)                  

  Endometrial                     23(2.9)            13(3.9)             10(2.2)                 

  Ovary                           18(2.3)            12(3.6)             6(1.3)                  

  Other                           174(22.1)          90(26.7)            84(18.7)                

                                                                                                 

  Stage (TNM)                                                                                    \< 0.001

  0-I                             106(13.5)          56(16.6)            50(11.1)                

  II                              122(15.5)          49(14.5)            73(16.3)                

  III                             202(25.7)          71(21.1)            131(29.2)               

  IV                              116(14.8)          35(10.4)            81(18.0)                

  Unknown                         240(30.5)          126(37.5)           114(25.4)               

                                                                                                 

  Time since diagnosis (months)                                                                  0.005

  ≦36                             537(68.3)          216(64.1)           321(71.5)               

  \>36, ≦48                       59(7.5)            23(6.8)             36(8.0)                 

  \>48, \<60                      27(3.4)            9(2.7)              18(4.0)                 

  ≧60                             153(19.5)          81(24.0)            72(16.0)                

  Unknown                         10(1.3)            8(2.4)              2(0.4)                  
  ----------------------------------------------------------------------------------------------------------

Data are presented as the actual number of patients (percentage in that group). Chi-square tests were conducted between Western medicine and Chinese medicine users.

###### 

Prevalence and patterns of treatments

  --------------------------------------------------------------------------------------------------------
  Variables                     No. of patients\   Western medicine\   Chinese medicine n(%)   *P*-value
                                n(%)               n(%)                                        
  ----------------------------- ------------------ ------------------- ----------------------- -----------
  Conventional treatment        781(99.4)          337(100)            444(98.9)               0.052

  Surgery                       453(57.6)          196(58.2)           257(57.2)               0.796

  Chemotherapy                  501(63.7)          184(54.6)           317(70.6)               \< 0.001

  Radiotherapy                  487(62.0)          208(61.7)           279(62.1)               0.905

  Endocrine therapy             84(10.7)           36(10.7)            48(10.7)                0.997

  Palliative therapy            12(1.5)            1(0.3)              11(2.4)                 0.015

                                                                                               

  Chinese medicine              449(57.1)          \-\--               449(100)                \-\--

  treatment                     424(53.9)          \-\--               424(94.4)               

  Chinese Herbal Medicine       21(2.7)            \-\--               21(4.7)                 

  Acupuncture and Moxibustion   11(1.4)            \-\--               11(2.4)                 

  Therapeutic Massage           40(5.1)            \-\--               40(8.9)                 

  *Qigong*                      75(9.5)            \-\--               75(16.7)                

  Chinese Dietary Therapy                                                                      
  --------------------------------------------------------------------------------------------------------

Data are presented as the actual number of patients (percentage in that group) who received Western medicine and Chinese medicine treatments.

The use profile of Western medicine treatment among the participants was as follows: chemotherapy (63.7%), radiotherapy (62.0%), surgery (57.6%), endocrine therapy (10.7%), and palliative therapy (1.5%) (Table [4](#T4){ref-type="table"}). Chinese herbal medicine (94.4%) was the most used Chinese medicine modality, followed by Chinese dietary therapy (16.7%) *qigong*(8.9%), acupuncture and moxibustion (4.7%) and therapeutic massage (2.4%) (Table [3](#T3){ref-type="table"}). Results showed that 62.6% of the participants received only Western medicine and 54.3% of the participants (N = 244) received both Western medicine and Chinese medicine were satisfied with their treatments (Figure [1](#F1){ref-type="fig"}).

###### 

Integrated pattern between Chinese treatment and five common anti-cancer Western medicine treatments

  Types of Chinese medicine treatment   No. of users   No. of Chinese medicine users (%)   Types of Chinese medicine treatment   No. of users (%)
  ------------------------------------- -------------- ----------------------------------- ------------------------------------- ------------------
  Total                                 781            449(57.1)                                                                 
                                                                                                                                 
  Surgery                               453            257(56.7)                           Chinese Herbal Medicine               243(53.6)
                                                                                           Acupuncture and Moxibustion           8(1.8)
                                                                                           Therapeutic Massage                   4(0.9)
                                                                                           *Qigong*                              25(5.5)
                                                                                           Chinese Dietary Therapy               51(11.3)
                                                                                                                                 
  Chemotherapy                          501            317(63.3)                           Chinese Herbal Medicine               301(60.1)
                                                                                           Acupuncture and Moxibustion           12(2.4)
                                                                                           Therapeutic Massage                   6(1.2)
                                                                                           *Qigong*                              28(5.6)
                                                                                           Chinese Dietary Therapy               50(10.0)
                                                                                                                                 
  Radiotherapy                          487            279(57.3)                           Chinese Herbal Medicine               265(54.4)
                                                                                           Acupuncture and Moxibustion           14(2.9)
                                                                                           Therapeutic Massage                   8(1.6)
                                                                                           *Qigong*                              24(4.9)
                                                                                           Chinese Dietary Therapy               49(10.1)
                                                                                                                                 
  Endocrine therapy                     84             48(57.1)                            Chinese Herbal Medicine               47(56.0)
                                                                                           Acupuncture and Moxibustion           2(2.4)
                                                                                           Therapeutic Massage                   2(2.4)
                                                                                           *Qigong*                              8(9.5)
                                                                                           Chinese Dietary Therapy               11(13.1)
                                                                                                                                 
  Palliative therapy                    12             11(91.7)                            Chinese Herbal Medicine               11(91.7)
                                                                                           Acupuncture and Moxibustion           1(8.3)
                                                                                           Therapeutic Massage                   2(16.7)
                                                                                           *Qigong*                              1(8.3)
                                                                                           Chinese Dietary Therapy               2(16.7)

Data are presented as the actual number of patients (percentage in that group).

![**Summary of factors contributing to patients\' preferences towards cancer treatments**.](1749-8546-4-25-1){#F1}

Among the participants who used Chinese medicine (N = 449), 67.9% (N = 305) as recommended by relatives, ward-mates or others, while 52.1% (N = 234) made their own choice. Only 3.8% (N = 17) of the participants were recommended to use Chinese medicine by their physicians. Nearly two-thirds of the participants (N = 274) did not tell their physicians about using Chinese medicine. Of 175 participants who consulted their physicians about their use of Chinese medicine, 49.7% (N = 87) physicians were neutral, 29.1% (N = 51) were for, whereas 20.0% (N = 35) against their use of Chinese medicine (Table [5](#T5){ref-type="table"}).

###### 

Motivation for Chinese medicine use among patients and communication with Western medicine physicians

  Characteristics                                                         N (%)
  ----------------------------------------------------------------------- ------------
  Motivation for using Chinese medicine (N = 449)                         
  Recommendation from relatives, ward-mates or others                     305 (67.9)
  Will of patients themselves                                             234 (52.1)
  Recommendations from physicians                                         17 (3.8)
  Other                                                                   6 (1.3)
  Consulted with Western medicine physicians about Chinese medicine use   
  Yes                                                                     175 (39.0)
  No                                                                      274 (61.0)
  If \'yes\', physician\'s response                                       
  Encourage                                                               51 (29.1)
  Neutral                                                                 87 (49.7)
  Discourage                                                              35 (20.0)
  Other                                                                   2 (1.1)
  If \'no\', why                                                          
  Doctor never asked                                                      129 (47.1)
  Patients thought Western medicine physician would not agree             116 (42.3)
  Unnecessary to inform Western medicine physician                        77 (28.1)
  Other                                                                   9 (3.3)

Data are presented as the actual number of patients (percentage in that group).

Factors contributing to treatment modality preference
-----------------------------------------------------

With the hopes to reduce side-effects from Western medicine (65.5%), suppress tumor progression (60.8%), relieve symptoms (57.5%) and improve quality of life (48.4%), 54.2% of the participants (N = 426) preferred combined Chinese medicine and Western medicine treatments. Out of 347 (44.1%) participants who used Western medicine only, 67.7% did so because they believed that Western medicine alone could suppress tumor progression (Table [6](#T6){ref-type="table"}).

###### 

Patients\' perspectives on the effectiveness of integrative Chinese and Western medicine (N = 786)

  --------------------------------------------------------------------------------------------------------------------------------------------
  Variables                                            Western medicine\   Chinese medicine n(%)   Integrative Chinese and Western medicine\
                                                       n(%)                                        n(%)
  ---------------------------------------------------- ------------------- ----------------------- -------------------------------------------
  Total                                                347(44.15%)         13((1.65%)              426(54.2%)

  Progression suppress                                 235(67.7%)          9(69.2%)                259(60.8%)

  Relieve the symptoms                                 83(23.9%)           10(76.9%)               245(57.5%)

  Reduce dosage of western medicine                                                                64(15%)

  Sufficient psychological support                     103(29.7%)          3(23.1%)                159(37.3%)

  Sufficient evidence                                  185(53.4%)          2(15.4%)                

  Promote the quality of life                          103(29.7%)          8(61.5%)                206(48.4%)

  Western medicine fails to suppress the progression                       7(53%)                  109(25.6%)

  Chinese medicine fails to suppress the progression                                               77(18.1%)
  --------------------------------------------------------------------------------------------------------------------------------------------

Over two-thirds of all participants (68.2%) believed that integrated Chinese and Western medicine was effective. Participants who were ambivalent about integrated Chinese and Western medicine effectiveness accounted for 31.4% (N = 245), while only 0.4% (N = 3) thought integrated medicine would not be effective (Figure [2](#F2){ref-type="fig"}).

![**Patients\' intention in the use of Chinese medicine, Western medicine or integrative Chinese and Western treatment in the future (N = 786)**.](1749-8546-4-25-2){#F2}

A total of 469 participants (59.7%) claimed that they would continue or try Chinese medicine as an alternative therapy in the future, while 63 participants (8.0%) would not consider using Chinese medicine only (Figure [3](#F3){ref-type="fig"}).

![**Patients\' satisfaction with their current treatment and the factors affecting their satisfaction levels**. Data are presented as the actual number of patients (percentage in that group).](1749-8546-4-25-3){#F3}

Demand for integrative Chinese-Western medicine treatment
---------------------------------------------------------

Regarding whether or not the Hong-Kong government should further promote the integration of Chinese medicine and Western medicine in cancer treatment, 690 participants (87.8%) agreed, 92 (11.7%) had no opinion, while only 4 (0.5%) thought it was unnecessary.

Discussion
==========

Among many studies reporting the use of CAM to treat cancer patients \[[@B2]-[@B7],[@B9],[@B19]-[@B21]\], few reports were based on large-scale survey. This survey interviewed a large number of patients (N = 786) with various types of cancers to evaluate the characteristics of their treatment as well as their attitudes towards Chinese medicine treatment. The present study indicates that the use of Chinese medicine in cancer treatment in Hong Kong (57.1%) is much more than that in Japan (7.1%) \[[@B7]\], but lower than that in the mainland China (100%) \[[@B6]\]. As overseas Chinese often think of Chinese medicine as their first choice of CAM \[[@B22],[@B23]\], this difference in the use of Chinese medicine may be due to socio-cultural difference among ethnics groups \[[@B22]\] rather than regional differences in medical systems.

Findings that cancer patients in Hong Kong favored Chinese herbal medication are consistent with previous studies \[[@B9],[@B22]\]. The present study discovered that nearly half (49.93%) of the participants recruited from Western medicine clinics used Chinese medicine. Several factors were found to encourage the use of Chinese medicine among cancer patients \[[@B7],[@B20],[@B24],[@B25]\], such as recommendations from the relatives and ward-mates, patients\' own willingness, and advice from physicians.

Sixty-one per cent (61.0%) of the participants never talked to their physicians about their use of Chinese medicine. Half of the physicians (49.7%) held neutral opinions towards Chinese medicine use; one-third (29.1%) accepted Chinese medicine use and 20% rejected it. Seventy percent (70%) of the participants believed that integration of Chinese medicine and Western medicine would have positive effects in cancer treatment. Approximately 90% of all participants thought that the Hong Kong government should develop integrative Chinese and Western medicine in cancer treatment. As such, we propose that communication among patients, physicians and Chinese medicine practitioners should be encouraged.

Biases may exist in this study as a result of the non-randomized recruitment method. A total of 117 (14.9%) participants were recruited from three HKBU Chinese medicine clinics. The use of Chinese medicine among these participants may be higher than the participants from ordinary clinics. The recruitment from the Oncology Outpatient Department excluded those patients from the palliative day-care clinics. Nevertheless, among the participants (N = 669) recruited from Western medicine clinics, nearly half (49.93%) did use Chinese medicine. Even though the sample may not be representative of all cancer patients in Hong Kong, the large scale and interesting findings of this study does warrant a more structured and population-based sample in the future.

Conclusion
==========

Our findings indicate that most cancer patients in Hong Kong considered integrative Chinese and Western medicine as an effective cancer treatment. Randomized controlled trials to evaluate Chinese medicine treatments, establishment of integrative Chinese and Western medical facilities, and public education about Chinese medicine are greatly demanded.
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